COVID-19 Proteases Inhibited by Repurposed FDA-Approved Drugs
Two notorious SARS-CoV-2 proteases—Mpro and PLpro—were inhibited by drugs that have already been approved for indications other than COVID-19. The identification of potentially useful SARS-CoV-2 antiviral drug…
Read guide →